Amgen dips after trial update for Zai Lab partnered gastric cancer therapy
Source: SeekingAlpha
2025-09-03 11:35:50 ET
More on Amgen, Zai Lab
- Back To Basics: Why I Favor Amgen Over Johnson & Johnson
- Zai Lab Limited (ZLAB) Q2 2025 Earnings Call Transcript
- Why I Still Don't Think Amgen Is A Buy
- Amgen to spend more than $500M to build new R&D center in California
- Trump says he will lower drug prices by as much as 1500%
Read the full article on Seeking Alpha
For further details see:
Amgen dips after trial update for Zai Lab partnered gastric cancer therapy
Zai Lab Limited
NASDAQ: ZLAB
ZLAB Trading
-2.23% G/L:
$19.08 Last:
148,553 Volume:
$19.22 Open:
ZLAB Latest News
February 26, 2026 07:00:00 am
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
ZLAB Stock Data
$2,174,273,322
105,108,310
0.9%
39
N/A
Biotechnology & Life Sciences
Healthcare
CN
Shanghai
